Related Experiment Videos
[Bifidogenic factors as drug preparations]
A O Murashova1, O B Lisitsin, N A Abramov
1Joint-Stock Company Partner, Moscow, Russia.
Zhurnal Mikrobiologii, Epidemiologii I Immunobiologii
|June 14, 2000
Summary
This review explores bifidogenic factors, emphasizing oligosaccharides like fructo-oligosaccharides, which stimulate beneficial bifidobacteria growth. Their use in probiotics depends on the severity of gut microflora disturbances.
Area of Science:
- Microbiology
- Gastroenterology
- Nutritional Science
Context:
- The gut microbiota plays a crucial role in host health.
- Dysbiosis, an imbalance in gut bacteria, is linked to various health issues.
- Bifidobacteria are key beneficial bacteria in the gut microbiome.
Purpose:
- To review current data on bifidobacterial factors and their mechanisms of action.
- To analyze the role of oligosaccharides, particularly fructo-oligosaccharides, in promoting bifidobacteria growth.
- To evaluate the application of bifidogenic factors in various health contexts.
Summary:
- This review examines bifidobacterial factors and their beneficial effects on intestinal microflora.
- Oligosaccharides, including fructo-oligosaccharides, are highlighted for their ability to stimulate bifidobacteria growth in vitro and in vivo.
- Methods to enhance the bifidogenic effect of natural compounds are discussed, alongside the potential use of these factors in medicinal preparations and probiotic formulations.
Impact:
- Understanding bifidogenic factors can lead to novel therapeutic strategies for gut health.
- The findings support the development of targeted probiotics and prebiotics to modulate the gut microbiome.
- Tailoring the use of bifidogenic factors based on the type and severity of microflora disturbances may optimize treatment outcomes.